• Mashup Score: 12
    ACC 2021 Prevention Highlights – ADAPTABLE and STRENGTH Trials - 3 year(s) ago

    ACC 2021 Prevention Highlights where CardioNerds discuss ADAPTABLE and STRENGTH Trials with Dr. Gina Lundberg and Dr. Steven Nissen

    Source: Cardionerds
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Dr_DanMD
      Dr_DanMD

      🎤#ACC2021 Prevention Highlights – #ADAPTABLE & #STRENGTH Trials with Drs. @gina_lundberg & Steven Nissen 🙏A collab with ACC Prevention of CV Disease Council @DrEugeneYang @AnumSaeedMD @mahrifai @CardioNerds @AmitGoyalMD @RichardAFerraro @ThomasMDas 🔗https://t.co/sIzwHTGfgn https://t.co/5FwtUdNnHz

  • Mashup Score: 0
    The Clinical Impact of the ADAPTABLE Trial - 3 year(s) ago

    W. Schuyler Jones, MD, and Manesh Patel, MD discuss the influences the aspirin-dosing cardiology trial may have on future studies.

    Source: HCPLive
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MDMagazine
      MDMagazine

      Watch cardiologists @schuyler_jones and @manesh_patelMD offer thoughts on what the #ADAPTABLE trial might mean for the future of cardiological research. #CardioTwitter #HeartTrials https://t.co/1aE8dDL6tj

  • Mashup Score: 1
    The Clinical Impact of the ADAPTABLE Trial - 3 year(s) ago

    W. Schuyler Jones, MD, and Manesh Patel, MD discuss the influences the aspirin-dosing cardiology trial may have on future studies.

    Source: HCPLive
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MDMagazine
      MDMagazine

      “More than anything, the process of the trial is important: can we do a pragmatic study on a limited budget in the United States in a relatively short period?" - @schuyler_jones on the potential impact of the #ADAPTABLE trial. #CardioTwitter https://t.co/1aE8dE2HkR

  • Mashup Score: 0
    The Clinical Impact of the ADAPTABLE Trial - 3 year(s) ago

    W. Schuyler Jones, MD, and Manesh Patel, MD discuss the influences the aspirin-dosing cardiology trial may have on future studies.

    Source: HCPLive
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MDMagazine
      MDMagazine

      Data from the #ADAPTABLE trial was presented at #ACC20 this year. HCPLive spoke with @schuyler_jones about the biggest takeaways from the study on Ep 1 of the #HeartTrials podcast. How might this trial potentially influence future clinical trials? https://t.co/1aE8dDL6tj https://t.co/DwLBvVYpKe

  • Mashup Score: 0
    ADAPTABLE: Low-dose aspirin as good as high-dose in CHD? - 3 year(s) ago

    A large randomized trial specifically designed to investigate the optimum dose of aspirin in patients with established coronary disease has found similar efficacy and safety with 81 mg and 325 mg.

    Source: www.mdedge.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MDedgeCardio
      MDedgeCardio

      #ACC21: No significant difference in cardiovascular events or major bleeding was shown between patients with established coronary heart disease assigned to a daily aspirin dose of 81 mg and those receiving a dose of 325 mg #ADAPTABLE trial. https://t.co/NPycP2qKrB https://t.co/qciPw0PFqL

  • Mashup Score: 1
    Video: Day 1 Highlights | ACC.21 - American College of Cardiology - 3 year(s) ago

    Dr. Kim Eagle, Dr. Deepak Bhatt, and Dr. Payal Kohli look back on Day 1 of ACC.201 late-breaking science and featured clinical research, including LAAOS III (0:38), ATLANTIS (4:07), ADAPTABLE (8:02), EXPLORER-HCM (13:25), and PARADISE-MI (16:59). Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Arrhythmias and Clinical EP, Atherosclerotic Disease (CAD/PAD),…

    Source: American College of Cardiology
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Cardiology
      Cardiology

      A new video featuring @keaglemd, @DLBHATTMD, and @payalkohlimd reflects on late-breaking science and featured clinical research from day one of #ACC21, including #LAAOS III, #ATLANTIS, #ADAPTABLE, EXPLORER-HCM, and #PARADISEMI! Watch it now: https://t.co/ySSemjqnYF https://t.co/BnJE33DKG0

  • Mashup Score: 3
    Video: Day 1 Highlights | ACC.21 - American College of Cardiology - 3 year(s) ago

    Dr. Kim Eagle, Dr. Deepak Bhatt, and Dr. Payal Kohli look back on Day 1 of ACC.201 late-breaking science and featured clinical research, including LAAOS III (0:38), ATLANTIS (4:07), ADAPTABLE (8:02), EXPLORER-HCM (13:25), and PARADISE-MI (16:59). Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Arrhythmias and Clinical EP, Atherosclerotic Disease (CAD/PAD),…

    Source: American College of Cardiology
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ACCinTouch
      ACCinTouch

      Catch up on the highlights from day 1 of #ACC21! @keaglemd, @DLBHATTMD, and @payalkohlimd look back on late-breaking science and featured clinical research, including #LAAOS III, #ATLANTIS, #ADAPTABLE, EXPLORER-HCM, and #PARADISEMI: https://t.co/szQxgLxLAH https://t.co/KXsO9kD2cV

Load More